0.18799999 EUR
0.004
2.17%
Last update Dec 12, 9:35 PM CET
Main market
Day range
0.18300000
0.18799999
Previous close
0.18400000
Open
0.18300000
Access this stock data via API
Subscribe
Northwest Biotherapeutics Inc.
0.19
0.00
2.17%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 1.2M 1.9M 1.7M 1.0M
Cost of revenue
Gross profit
Operating expense
Research & development 29.7M 27.7M 35.5M 20.3M
Selling general and admin 28.1M 29.7M 33.4M 33.4M
Other operating expenses
Operating income -56.6M -55.5M -67.2M -52.7M
Non operating interest income
Income
Expense 6.6M 5.2M 6.1M 5.0M
Other income expense -8.1M -1.9M -31.8M 236.8M
Pretax income -71.4M -62.6M -105.0M 179.1M
Tax provision
Net income -71.4M -62.6M -105.0M 179.1M
Basic EPS -0.1 -0.1 -0.1 0.2
Diluted EPS -0.1 -0.1 -0.1 -0.1
Basic average shares 1.1B 1.2B 1.0B 896.9M
Diluted average shares 1.1B 1.2B 1.0B 896.9M
EBITDA -55.6M -53.9M -65.6M -52.8M
Net income from continuing op. -71.4M -62.6M -105.0M 179.1M
Minority interests
Preferred stock dividends 1.2M 1.8M 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 43 minutes

11:16
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).